AEPCX
Price
$59.44
Change
+$0.30 (+0.51%)
Updated
Sep 5 closing price
Net Assets
132.86B
FDIVX
Price
$50.00
Change
+$0.16 (+0.32%)
Updated
Sep 5 closing price
Net Assets
12.75B
Interact to see
Advertisement

AEPCX vs FDIVX

Header iconAEPCX vs FDIVX Comparison
Open Charts AEPCX vs FDIVXBanner chart's image
American Funds EUPAC C
Price$59.44
Change+$0.30 (+0.51%)
VolumeN/A
Net Assets132.86B
Fidelity Diversified International
Price$50.00
Change+$0.16 (+0.32%)
VolumeN/A
Net Assets12.75B
AEPCX vs FDIVX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
AEPCX vs. FDIVX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and FDIVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. FDIVX (12.7B). FDIVX pays higher dividends than AEPCX: FDIVX (1.70) vs AEPCX (0.16). AEPCX was incepted earlier than FDIVX: AEPCX (25 years) vs FDIVX (34 years). AEPCX (1.57) is less costly to investors than FDIVX (0.59). AEPCX (35.00) and FDIVX (35.00) have comparable annual turnover. FDIVX has a lower initial minimum investment than AEPCX: FDIVX (0) vs AEPCX (250). FDIVX annual gain was more profitable for investors over the last year : 12.30 vs. AEPCX (7.59). FDIVX return over 5 years is better than : 23.18 vs. AEPCX (7.78).
AEPCXFDIVXAEPCX / FDIVX
Total Expense Ratio1.570.59266%
Annual Report Gross Expense Ratio1.570.59266%
Fund Existence25 years34 years-
Gain YTD15.03818.59681%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets133B12.7B1,047%
Annual Yield % from dividends0.161.7010%
Returns for 1 year7.5912.3062%
Returns for 3 years32.6549.8865%
Returns for 5 years7.7823.1834%
Returns for 10 years34.3450.2668%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PACB1.270.03
+2.42%
Pacific Biosciences of California
VVX56.681.23
+2.22%
V2X
GANX1.760.02
+1.15%
Gain Therapeutics
LINE40.590.13
+0.32%
Lineage Inc.
QVCGP6.980.02
+0.29%
QVC Group Inc.